LOGO
LOGO

Pre-market Movers: CHRO, QURE, FOTA, LLY...

By RTTNews Staff Writer   ✉  | Published:  | Google News Follow Us  | Join Us
rttnewslogo20mar2024 lt

Stocks in the biotech space, that are making big moves in pre-market on Thursday are (as of 8.15 am ET).

In the Green

Channel Therapeutics Corporation (CHRO) is up over 82% at $2.29.
uniQure N.V. (QURE) is up over 51% at $14.21.
Sharps Technology, Inc. (STSS) is up over 38% at $0.04.
Eli Lilly and Company (LLY) is up over 12% at $828.80.
InnovAge Holding Corp. (INNV) is up over 12% at $3.20.
OneMedNet Corporation (ONMD) is up over 12% at $0.53.
IN8bio, Inc. (INAB) is up over 11% at $0.18.
China SXT Pharmaceuticals, Inc. (SXTC) is up over 10% at $1.10.
Clearmind Medicine Inc. (CMND) is up over 9% at $1.06.
Syra Health Corp. (SYRA)is up over 9% at $0.14.
Acurx Pharmaceuticals, Inc. (ACXP) is up over 8% at $0.42.
ProKidney Corp. (PROK) is up over 8% at $0.86.
CERo Therapeutics Holdings, Inc. (CERO) is up over 7% at $0.64.
Kairos Pharma, Ltd. (KAPA) is up over 7% at $0.98.
Lexaria Bioscience Corp. (LEXX) is up over 7% at $1.50.
Akanda Corp. (AKAN) is up over 7% at $1.20.
Monopar Therapeutics Inc. (MNPR) is up over 6% at $40.65.
Tenet Healthcare Corporation (THC) is up over 6% at $128.12.
KalVista Pharmaceuticals, Inc. (KALV) is up over 5% at $12.40.

Subscribe to continue reading the article.
This article is available exclusively to RTT Biotech Investor and Intelligent Investor subscribers. Subscribe with a RTTNews subscription.
Start Free Trial
FREE 7-Day Trial - No Payment Required
Already subscribed? Sign in

For comments and feedback contact: editorial@rttnews.com

Global Economics Weekly Update - Jun 01 - Jun 05, 2026

June 05, 2026 16:18 ET
A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.

Latest Updates on COVID-19